Optimising the therapeutic ratio in head and neck cancer
Authors:
- June CorryJCJune Corry
- Lester J PetersLPLester J Peters
- Danny RischinDRDanny Rischin
- 1 March 2010
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 11 (3) , 287-291
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225Journal of Clinical Oncology, 2009
- Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma?International Journal of Cancer, 2009
- Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and NeckClinical Cancer Research, 2009
- Post-Laryngectomy: It’s Hard to SwallowDysphagia, 2008
- Proximal Esophageal Stenosis in Head and Neck Cancer Patients after Total Laryngectomy and RadiationORL, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- The role of post–radiation therapy fdg pet in prediction of necessity for post–radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck CancerJournal of Clinical Oncology, 2003
- A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patientsEuropean Journal of Cancer, 2000